BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang X, Hong Y, Xie SY, Liao HL, Huang HM, Liu JH, Long WJ. Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report. World J Clin Cases 2022; 10(28): 10317-10325 [PMID: 36246798 DOI: 10.12998/wjcc.v10.i28.10317]
URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10317.htm
Number Citing Articles
1
Cisplatin/pemetrexedReactions Weekly 2023; 1944(1): 204 doi: 10.1007/s40278-023-33723-1
2
Xiao-Dong Peng, Zhen-Yu You, Lian-Xiang He, Qi Deng. Zimberelimab plus chemotherapy as the first-line treatment of malignant peritoneal mesothelioma: A case report and review of literatureWorld Journal of Clinical Cases 2023; 11(22): 5290 doi: 10.12998/wjcc.v11.i22.5290
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
3
Xiao-Dong Peng, Zhen-Yu You, Lian-Xiang He, Qi Deng. Zimberelimab plus chemotherapy as the first-line treatment of malignant peritoneal mesothelioma: A case report and review of literatureWorld Journal of Clinical Cases 2023; 11(22): 5296-5302 doi: 10.12998/wjcc.v11.i22.5296
4
Marie-Florence Reveneau, Julien Masliah-Planchon, Manuel Fernandez, Abdenour Ouikene, Bernard Dron, Innocenti Dadamessi, Charles Dayen, Lisa Golmard, Bruno Chauffert. Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literatureFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1410322